Bodyfriend CEO Doyun Kwak: "Healthcare Robot 733, the Culmination of 20 Years of Technology"

Launch Conference Held at Dogok Lounge on the 24th

Equipped with Second-Generation Robotics Technology

Simultaneous Arm and Leg Movement Enables Shoulder and Ankle Stretching

Annual Sales Target Set at Up to 10,000 Units

As the music began, six healthcare robots placed on the stage started moving in perfect unison. To the upbeat rhythm, they alternately lifted their left and right arms toward the ceiling, then bent their torsos backward and stretched both legs up toward the ceiling. From the audience came remarks that it looked just like "Bumblebee."

The Bodyfriend healthcare robot '733' is performing a military dance at the '733 Launch Conference' held on the 24th at the Dogok Lounge in Gangnam-gu, Seoul. Photo by Seo Hee Lee

On the 24th, Bodyfriend held a launch conference for its healthcare robot "733" at the Dogok Lounge in Gangnam-gu, Seoul. Key executives, including CEO Doyun Kwak, Director of Product Planning Sangman Yoon, and Head of Design Research Ilsu Yeom, attended the event.

At the event, CEO Kwak described the new 733 as a "culmination of Bodyfriend's 20 years of technology and expertise." He said, "We named the product '733' to reflect our pride, as it embodies Bodyfriend's journey since its founding on March 3, 2007." He emphasized, "As the era of physical AI takes over the world, Bodyfriend is ready to make a quantum leap with the 733."

The 733 healthcare robot first attracted attention from international buyers and visitors at CES 2026 in Las Vegas, United States, this January for its technology that enables simultaneous movement of its arms and legs. It is the first product to incorporate Bodyfriend's second-generation robotics technology. Whereas the first generation allowed the legs to operate independently, the new model adds movement where the legs fold toward the upper body, helping contract and relax muscles around the hip joint. New features also include technology for vertical arm movement and dorsiflexion of the feet, enabling stretching of shoulder and ankle muscles.

New AI-powered software has also been introduced. When users input physical information such as age, gender, and weight, as well as personal characteristics like fortune, personality type, and zodiac sign, the system recommends the optimal massage program for each user.

Doyon Kwak, CEO of Bodyfriend, is presenting the product at the '733 Launch Conference' held on the 24th at the Dogok Lounge in Gangnam-gu, Seoul. Photo by Seohui Lee

Bodyfriend is aiming for maximum annual domestic and international sales of up to 10,000 units of the 733. The current high-end healthcare robot market is valued at around 40–50 billion won, and with this launch, there is anticipation that the market size could expand significantly.

The company also announced plans to continue aggressive investment in research and development (R&D). Over the past five years, Bodyfriend has invested more than 100 billion won in R&D. Sangman Yoon, Director of Product Planning, stated, "With 794 accumulated registered patents over the past 20 years, Bodyfriend is undoubtedly the leader among small and mid-sized healthcare companies." He explained, "Through generous R&D, our 'technology export'—exporting technologies to global manufacturers in the form of licenses—has also been growing exponentially every year."

This content was produced with the assistance of AI translation services.